Replies to post #306979 on Elite Pharmaceuticals Inc (ELTP)

[namtae]

Basic stuff. Hard to understand the debate going on. You've made your point crystal clear..thanks

[WeeZuhl]

and while I am correcting the record here from a medical perspective, it is important to point out that the phase 2 study of isradipine was a safety and, tolerability study, not efficiacy

What record are you correcting? Nobody said otherwise. Thanks for nothing, as usual.